Today: 9 June 2026
TTM Technologies stock jumps as Raytheon’s $200 million deal and S&P MidCap 400 move stir buying
30 January 2026
1 min read

TTM Technologies stock jumps as Raytheon’s $200 million deal and S&P MidCap 400 move stir buying

New York, January 30, 2026, 14:04 EST — Regular session

  • TTMI climbed 3.7% in afternoon trading, bouncing between $95.06 and $103.36 earlier in the session
  • Company revealed a multi-year supply agreement with Raytheon, valued at up to $200 million
  • Investors are focused on the Feb. 4 results and the company’s 2026 outlook

TTM Technologies shares rose 3.7% to $100.03 Friday afternoon, bouncing back after an initial drop as investors reacted to new defense-contract news and picked up shares linked to index activity. The stock swung between $95.06 and $103.36, with roughly 1.8 million shares changing hands.

Timing is crucial. A multi-year defense contract provides suppliers steady work and clearer planning over extended programs. Shifts in the index can also trigger automatic buying, no matter what anyone thinks about the valuation.

The stock slips into a packed field of hardware and defense names, where any sign of slowing orders gets punished fast. With TTM’s quarterly update coming next week, traders see Friday’s rally more as a prelude than a finish line.

Late Wednesday, Costa Mesa-based TTM Technologies announced that Raytheon, part of RTX, secured a multi-year contract for radio frequency assemblies, electronic hardware, and printed circuit boards tied to the Lower Tier Air and Missile Defense Sensor radar program. The deal could be worth up to $200 million across three years. Mike Mills highlighted that the agreement supports “our accelerated delivery schedule while reducing costs.” Catherine Gridley of TTM described the move as one that “reinforces our long-standing partnership with Raytheon.” TTM Technologies, Inc.

Aside from the contract win, S&P Dow Jones Indices announced that TTM has been added to the S&P MidCap 400, effective before Friday’s open, moving out of the S&P SmallCap 600.

Index reshuffling like this often sparks quick, intense moves as passive funds realign their holdings. But these bursts usually subside fast, with the stock settling back into trading based on fundamentals.

Defense primes showed a mixed performance on Friday. RTX held steady, Lockheed Martin gained roughly 1%, and Northrop Grumman dropped close to 1.3%.

TTM is set to report its fourth-quarter 2025 earnings on Feb. 4, holding a conference call at 4:30 p.m. EST. The results will be released after the market closes.

However, the rally carries a distinct risk. That $200 million number is only “potential” value, with progress tied to program timelines and client demand; margins can shift even if revenue appears steady. A cautious note on Feb. 4 — or any hint of weakening orders — might reverse some of the gains from index moves and contracts.

Traders are focused on whether Friday’s gains stick through the close and carry over into next week’s positioning. The next major event is Feb. 4, when management will report results and provide guidance.

Stock Market Today

  • NSE Allocates 10% of Annual CSR Fund to Social Stock Exchange
    June 9, 2026, 10:16 AM EDT. The National Stock Exchange (NSE) will deploy 10% of its annual Corporate Social Responsibility (CSR) corpus through the Social Stock Exchange, signaling trust in this market-based platform designed to connect social enterprises with investors. This move aims to enhance transparency and impact investing by leveraging the exchange's resources to support social causes.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
Johnson & Johnson stock today: JNJ steadies after talc court win, EU panel backs AKEEGA expansion
Previous Story

Johnson & Johnson stock today: JNJ steadies after talc court win, EU panel backs AKEEGA expansion

Joby Aviation stock drops again as $1.2 billion capital raise puts dilution back in focus
Next Story

Joby Aviation stock drops again as $1.2 billion capital raise puts dilution back in focus

Go toTop